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It has not been possible to obtain in vitro expression of the positively regulated malE gene encoding the
periplasmic maltose-binding protein (MBP) of Escherichia coli. To facilitate in vitro malE expression, we
constructed plasmids that place the malE gene under transcriptional control of the lacUV5 promoter-operator.
These plasmids could be grouped into three classes, based upon their ability to complement in vivo a
chromosomal malE deletion in the presence or absence of isopropyl thiogalactoside. In the one class I plasmid
analyzed, the lacUV5-malE junction was just 3' to the malE ATG initiation codon, and this plasmid did not
complement the malE deletion. Class II and class III plasmids retained various amounts of the malE promoter.
MBP synthesis was solely under control of the lacUV5 promoter in the class II plasmids, and MBP synthesis
was under control of both the lacUV5 and malE promoters in the class III plasmids. A malE mutation that
renders the MBP signal peptide export defective was genetically recombined onto one of the class II plasmids.
The in vivo synthesis and export of plasmid-encoded MBP were studied in the presence and absence of
isopropyl thiogalactoside and maltose and in a strain harboring a prLA mutation that suppresses the malE signal
sequence mutation and is thought to alter the export machinery of cells. In addition, both class II and class III
plasmids programmed the synthesis of precursor MBP in an in vitro-coupled transcription-translation system.
When precursor MBP was synthesized in vitro in the presence of E. coli membrane vesicles, a significant
portion of wild-type precursor MBP, but not export-defective precursor MBP, was converted to a form that
migrated on sodium dodecyl sulfate-polyacrylamide gels identically to mature MBP synthesized in vivo.
The maltose-binding protein (MBP) of Escherichia coli,
the malE gene product, is an extracytoplasmic protein.
Although it is synthesized on ribosomes located within the
confines of the cytoplasmic membrane, its final cellular
location is the periplasm. The synthesis and export of the
MBP have been extensively investigated in several labora-
tories. The early steps in MBP export appear to be analogous
to those of other exported proteins in both procaryotic and
eucaryotic systems. The MBP is synthesized on polysomes
bound to the cytoplasmic membrane (28, 30, 31). It is
initially synthesized as a higher-molecular-weight precursor
which has an amino-terminal signal peptide of 26 residues (6)
and is thought to be chiefly responsible for initiating export
of the protein while it is still a nascent chain attached to a
ribosome (11, 27). Translocation of the MBP across the
cytoplasmic membrane and proteolytic cleavage of the signal
peptide have been demonstrated to occur both cotranslation-
ally and posttranslationally, but only after at least 80% of the
nascent chain has been synthesized (16, 27). These findings
indicate that elongation and translocation are not tightly
coupled events.
Much of the information concerning the mechanism of
MBP synthesis and secretion has resulted from analyses of
E. coli mutants with mutations affecting these processes
(recently reviewed in reference 3). Biochemical approaches
have also furthered our understanding, but have been more
limited (recently reviewed in reference 29). Attempts to
develop an in vitro procaryotic system capable of efficiently
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synthesizing and exporting MBP have been hindered by two
major obstacles. First, the absence of specific organelles
utilized for protein export in E. coli and other procaryotes
has slowed the development of a purified protein-exporting
system. However, workers in several laboratories have
recently reported considerable success in this area (9, 24,
25), indicating that similar studies with MBP may now be
feasible. Second, past attempts to synthesize MBP in an in
vitro, coupled transcription-translation system by using a
wild-type malE DNA template have been unsuccessful. It
was believed that expression of the malEFG operon was not
initiated in S30 extracts due to inadequate levels of func-
tional MalT protein, the positive effector of the mal regulon
(10).
In an earlier study, Marchal et al. (21) were able to study
the in vitro synthesis and maturation of the LamB protein,
which is encoded by a second gene in the mal regulon
(lamB), by placing it under transcriptional control of the
lacUV5 promoter-operator. Expression from this promoter
is regulated by the LacI repressor, is inducible with
isopropyl thiogalactoside (IPTG), and is independent of
cyclic AMP-mediated catabolite repression (18). In addition,
this promoter is an active promoter in vitro. We describe
here the construction of lacUV5-malE plasmids. We ana-
lyzed the in vivo synthesis of plasmid-encoded MBP in
several different E. coli strains and under different growth
conditions. In addition, these plasmids were used to direct
the synthesis of precursor MBP (pMBP) in vitro. When
pMBP was synthesized in the presence of E. coli membrane
vesicles, a significant portion of wild-type pMBP, but not
export-defective pMBP, was converted to the apparently
mature form.
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MATERIALS AND METHODS
Bacterial strains and plasmids. Most of the bacterial strains
used in this study are isogenic derivatives of E. coli strain
ECB526 (MC4100 [8] lac+ lacIqIF' lacIq TnS; obtained from
S. Benson, Princeton University). Strain BAR1091 is strain
ECB526 containing the malEA312 mutation, an inframe,
nonpolar deletion that removes DNA sequences encoding
residue 15 of the MBP signal peptide through residue 159 of
the mature MBP (mMBP) (V. A. Bankaitis and P. J. Bassford,
Jr., unpublished data). Strains BAR1092 and BAR1134 are
strains BAR1091 and ECB526, respectively, harboring the
prlA402 mutation (1). The malEA312 and prlA402 alleles were
introduced into strain ECB526 by P1 transduction. Strain
KK2186, which was used to propagate bacteriophage M13,
also was obtained from S. Benson. Plasmid pGL101 (18) was
used as the source of the lacUV5 promoter and was provided
by G. Bogosian, University of North Carolina. Plasmid pCL
was obtained from C. Lee (Harvard Medical School) via H.
Shuman (Columbia University). The S30 extracts were
prepared from either E. coli strain CF300 (DNase-), which
was provided by M. Cashel (National Institutes of Health), or
strain MRE600 (RNase I-), which was provided by H. Inouye
(Harvard Medical School). The S100 extracts, purified
ribosomes, and membrane vesicles were prepared from strain
MRE600.
Reagents. Minimal medium M63 supplemented with glyc-
erol (0.4%) and thiamine (2 ,ug/ml) and maltose-tetrazolium
indicator agar were prepared as described previously (23).
When used, ampicillin was added to liquid medium at a
concentration of 20 mg/liter and to plate medium at a
concentration of 100 mg/liter. Maltose, glycerol, and methi-
onine were purchased as reagent grade chemicals from
Fisher Scientific Co. Rabbit anti-MBP has been described
previously (13). Restriction enzymes, T4 DNA ligase, and
Bal 31 exonuclease were purchased from Bethesda Research
Laboratories, Inc. [35S]methionine (10 mCi/ml) was pur-
chased from Amersham Corp. [32P]ATP (800 Ci/mmol) was
obtained from New England Nuclear Corp.
Plasmid isolation and genetic techniques. Large-scale plas-
mid preparations were made as described previously (34).
Plasmids used for in vitro translation studies were banded
twice in CsCl, ethanol precipitated, and suspended in 10 mM
Tris (pH 8.0) at a concentration of 1 to 2 mg/ml. Mini-scale
plasmid preparations were obtained as previously described
(34). For DNA manipulation and cloning experiments, a 10
to 100-ml scaled-up version of the mini plasmid preparation
was used. The DNA was incubated with heat-treated RNase,
phenol extracted, ethanol precipitated, and suspended in 1
mM Tris (pH 8.0)-0.1 mM EDTA. The other standard DNA
and genetic techniques used have been described previously
(19, 23, 34).
Construction of plasmids carrying malE under control of the
lacUV5 promoter-operator. Plasmid pCL was digested with
EcoRI, and then 8-pmol ends of the linearized plasmid were
treated with 0.6 U of Bal 31 exonuclease for 28 min at 30°C.
We calculated that this removed approximately 400 base
pairs (bp) from each free end. Bal 31 activity was stopped by
extracting the reaction mixture with phenol, followed by
ethanol precipitation. The treated plasmid was next re-
stricted with PstI and ligated to a purified PstI-PvuII frag-
ment carrying the lacUV5 promoter. The ligated DNA was
used to transform strain BAR1091. Transformants were
selected on maltose-tetrazolium-ampicillin plates. These
transformants were screened for an IPTG-inducible Mal'
phenotype by streaking them onto maltose-tetrazolium agar
and looking for transformants that formed white colonies
when 1 mM IPTG was incorporated into the medium. The
lacUVS promoter fragment was obtained by digesting plas-
mid pGL101 simultaneously with PstI and PvuII. The DNA
fragments were resolved on a 5% polyacrylamide gel, and
the 851-bp lacUVS fragment was excised and eluted from the
gel as previously described (2).
Sequencing of the lacUV5-malE fusion joint. The lacUV5-
malEjunction is included on an EcoRI-BglII fragment that is
less than 1 kilobase long. This fragment was isolated by
restricting the appropriate plasmids with EcoRI and then
with BglII. These fragments were inserted between the
unique EcoRI and BamHI sites of bacteriophage M13mp8
RF (22), and the DNA sequence in the region of the
lacUV5-malE junction was determined by using the dideoxy
sequencing method of Sanger et al. (32). A 77-bp TaqI-TaqI
fragment (plasmids pBAR2, pBAR4, and pBAR5) and a
39-bp AvaII-Hinfl fragment (plasmids pBAR1, pBAR3,
pBAR26, and pBAR43) were used as primers for the se-
quencing reactions (2).
Genetic recombination of the malE18-1 signal sequence
mutation onto plasmid pBAR43. A strain carrying plasmid
pBAR43 was lysogenized with Aap malB13 (cI857 s7) (20)
onto which the malE18-1 mutation had been recombined as
previously described (2), and heat-induced phage lysates
were prepared. A very small fraction of the phage carried an
integrated copy of plasmid pBAR43 as a result of a single
crossover event between homologous malB sequences. Cells
of strain BAR1091 were infected with this lysate and plated
onto maltose-tetrazolium-ampicillin agar at 42°C. Transduc-
tion to Ampr and survival at 42°C required that the integrated
plasmid be excised from the phage DNA, most probably by
homologous recombination, and establish itself in the recip-
ient cell; the phage DNA was subsequently cured. Plasmid
integration into the phage genome in the donor strain and
subsequent excision in the recipient strain could occur by
different crossover events and may have resulted in the
acquisition of the malE18-1 mutation by the plasmid. Sur-
viving colonies were screened to determine their IPTG-
inducible Mal phenotypes as described above. One colony
exhibiting a Mal- phenotype in the presence of IPTG was
identified. The malE signal sequence coding region of the
plasmid from this strain was sequenced as described above,
confirming the presence of the maIE18-1 mutation on the
plasmid.
Pulse radiolabeling. Cells were grown in glycerol minimal
medium at 30°C with aeration. MBP synthesis was induced
by adding 5 mM IPTG or 0.4% maltose or both to a
mid-log-phase culture (optical density at 600 nm, 0.3 to 0.35).
After induction for 45 min, 1 ml of the culture was removed
and mixed with 5 ptCi of [35S]methionine for 1 min. Incor-
poration of label was terminated by adding 0.5 ml of 15%
trichloroacetic acid and immersing the preparation in an ice
water bath. The trichloroacetic acid precipitates were
pelleted, washed once with acetone, air dried, suspended in
100 ,ul of 10 mM Tris (pH 7.5)-i mM EDTA-1% sodium
dodecyl sulfate (SDS), and solubilized by heating in a boiling
water bath for 3 min. These labeled antigen extracts were
used in the radioimmunoprecipitation reactions described
below.
Pulse-chase experiments. Cells were grown and induced as
described above. At 45 min postinduction, 1.5 ml of a culture
was removed and mixed with 7.5 ,uCi of [35S]methionine for
1 min. Incorporation of label was terminated by adding 1.5
ml of glycerol minimal medium containing 0.8% unlabeled
methionine. Immediately after addition of the chase solu-
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tion, 1 ml of the culture was removed, mixed with 0.5 ml of
15% trichloroacetic acid, and placed in an ice water bath. At
10 min after the chase solution was added, a second 1-ml
portion of culture was removed and treated as described
above. Antigen extracts were prepared from the trichloro-
acetic acid precipitates as described above.
Radioimmunoprecipitation and SDS-polyacrylamide gel
electrophoresis. MBP species were immune precipitated
from radiolabeled antigen extracts as previously described
(13) by using rabbit anti-MBP serum, and the precipitates
were analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) and autoradiography as previously described (2,
13).
In vitro protein synthesis and processing. Plasmid-encoded
proteins were synthesized in vitro by using coupled tran-
scription-translation systems. The S30 fraction was prepared
from strain CF300 as previously described (23), except that
CaCl2 was omitted and polyethylene glycol 8000 (16 mg/ml)
and spermidine (2 mM) were added. For translocation ex-
periments, the S30 fraction and crude membranes were
prepared from strain MRE600 by the procedure of Muller
and Blobel (25); the S100 fraction was prepared from the S30
fraction by centrifugation at 120,000 x g for 15 min. Purified
ribosomes were prepared from the S30 fraction by centrifu-
gation and washing with Triton X-100 (manuscript in prepa-
ration). The DNA concentration was approximately 2 ,ug/25-
,ul reaction mixture.
RESULTS
Placement of the malE gene under transcriptional control of
the lacUV5 promoter-operator. Plasmid pCL carries a seg-
ment of the E. coli malB region, including the complete malB
regulatory interval and an intact malE gene. The nucleotide
sequence of the malB regulatory interval (7, 12) revealed no
convenient restriction endonuclease sites that would permit
us to simply excise the unwanted promoter for the malE
gene (malEp) and substitute the lacUV5 promoter-operator.
Therefore, as shown in Fig. 1, we attempted to remove
malEp from in front of the malE gene by using exonuclease
Bal 31. After Bal 31 treatment, the lacUVS promoter-
operator region was moved in front of the malE gene on a
PstI-PvuII fragment. After ligation, the plasmid mixture was
transformed into strain BAR1091, selecting for Ampr. Fifty
Ampr transductants were purified and tested for the ability of
their plasmids to complement, in the presence and absence
of IPTG, the internal malEA312 deletion carried on the
bacterial chromosome. Three different classes of plasmids
were recognized on the basis of the observed Mal pheno-
types. Strains harboring a class I plasmid were Mal- in the
presence or absence of IPIG; strains harboring a class II
plasmid were Mal- or weakly Mal' in the absence of IPITG
but strongly Mal' in the presence of IPTG; and strains
harboring a class III plasmid were strongly Mal' in the
presence or absence of IPTIG. It should be noted that strains
carrying a class III plasmid exhibited a significantly stronger
Mal+ phenotype than did a strain harboring the parental
malE+ plasmid pCL. A total of seven plasmids, including
representatives of each class, were selected for further
study.
Junction between the lacUVS promoter-operator and the
malE gene. For each of seven different plasmids, the exact
site at which the lacUVS promoter-operator fragment had
been joined to the malE gene was determined by DNA
sequencing, as described in Materials and Methods (Fig. 2).
The fusion joint for class I plasmid pBAR3 was found to lie
just within the malE structural gene. The lacUV5 promoter-
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FIG. 1. Construction of plasmids carrying malE under lacUVS
control. The malB region of the E. coli chromosome is shown at the
top. This region is composed of two divergent operons, the malEFG
operon and the malK-lamB operon. The region between these two
operons is termed the malB regulatory interval. The fragment
extending from the StuI restriction site in the malF gene to the
EcoRI site in the malK gene was cloned into plasmid pBR322,
generating plasmid pCL. To construct the pBAR plasmids, plasmid
pCL was first restricted with EcoRI. The linearized plasmid was
next treated with Bal 31 exonuclease to remove the malK coding
region and much of the malB regulatory interval. The DNA was
subsequently restricted with PstI. A PstI-PvuII fragment derived
from plasmid pGL101, carrying the lacUVS promoter-operator
sequence and the amino-terminal coding region for the Ampr
marker, was ligated to treated plasmid pCL DNA. See the text for
additional experimental details.
operator in class II plasmids pBAR26, pBAR43, and pBAR1
was fused 1, 10, and 38 bp, respectively, upstream from the
malE ATG initiation codon. All three plasmids were missing
the -10 and -35 regions of malEp identified by Bedouelle
and Hofnung (7). For plasmids pBAR26 and pBAR43, the
malE Shine-Dalgarno sequence also had been removed.
These sequences, which are presumably required for malE
expression, can be provided by the lacUV5 insertion, the
PvuII site being 5 bp downstream from the lac Shine-
Dalgarno sequence (18). Plasmid pBAR2 also was desig-
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GTTGCTTGCAAAAATCGT GGCGATTTTATGTGCGCA TCTCCACAT TACCGCCAA TTCTGTAAC AGAGATCAC ACAAAGCGA CGGTGGGGC
mRNA 1 pBAR1 pBAR43
GTAGGGGCAAGGAGGATGGAAAGAGGTTGCCGTATAMGAAACTAGAGTCCGTTTAGGTGTTTTCACGAGCACTTCACCAACAAGGACCA
MalT -35 -10 S-D
pBAR26 pBAR3
4 ffi Processing Site
TAGATTATG AAAATAAAAACAGGTGCA CGCATCCTC GCATTATCC GCATTAACG ACGATGATGTTTTCCGCC TCGGCTCTC GC+AAATC
met lys ile lys thr gly ala arg Ile lou ala leu ser ala leu thr thr met met phe ser ala ser ala leu ala lys ile
AGG
arg
FIG. 2. lacUV5-malE fusion joints for seven different pBAR plasmids. The nucleotide sequence for the malE sense strand is shown,
beginning with the malK coding sequence and extending 84 nucleotides into the malE structural gene (7, 12). The EcoRI restriction site in
malK is located 134 nucleotides upstream from the sequence given. The narrow lines underline the -10 and -35 sequences for both the malE
and malK genes. The Shine-Dalgarno sequence (S-D) for the malE gene is also underlined. The thick lines underline DNA sequences believed
to represent at least portions of the activation sites for the MalT protein (5). Transcription initiates at the positions of the vertical bars; the
attached arrows indicate the direction of transcription. The amino acid sequence for the MBP signal peptide and the first two residues of the
mature protein (6) is shown below its coding region. The nucleotide substitution and amino acid alteration resulting from the malE18-1
mutation (6) are indicated by an arrow. The lacUVS-malE fusion joints and their respective plasmid designations are indicated by the arrows
above the nucleotide sequence. DNA to the left of the arrows was removed and replaced with the lacUV5 promoter-operator fragment.
ing this plasmid was weakly Mal' in the absence of IPTG.
Note that this plasmid retained both the -10 and -35
regions of malEp. The class III plasmids pBAR4 and pBAR5
retained a large portion of the malB regulatory interval (more
than 200 bp). Included in this region was a sequence believed
to be required for activation of the malEFG operon by the
MalT protein (5). These plasmids had lost the -10 and -35
regions for the malK-lamB operon, as well as an upstream
sequence proposed to be required for activation of this
divergent operon by MalT (5).
In vivo synthesis of plasmid-encoded MBP in the presence
and absence of Inducers. Not unexpectedly, we were unable
to identify a MBP species encoded by class I plasmid pBAR3
(data not shown). The in vivo synthesis of MBP encoded by
plasmid pCL and several representative class II and III
plasmids described above was studied in the presence and
absence of maltose and IPTG. Cells were radiolabeled with
[35S]methionine for 1 min, and the MBP species were im-
munoprecipitated and analyzed by SDS-PAGE and autora-
diography, as described in Materials and Methods (Fig. 3).
For parental strain ECB526 having a single chromosomal
malE+ gene, only a small amount ofMBP was synthesized in
the absence of maltose. There was an approximately 10-fold
increase in MBP synthesis when maltose was added to the
growth medium. In a strain in which malE+ was carried on
multicopy plasmid pCL, a relatively large amount of MBP
was synthesized in the absence of maltose. In this instance,
only a two- to threefold increase in MBP synthesis was
observed in the presence of maltose. As expected, the
addition of IPTG had no effect on the amount of MBP
synthesized by either strain, and MBP synthesis was not
detectable when either of these strains harbored a malT
deletion mutation.
In contrast to these results, cells carrying class II plasmid
pBAR1 or pBAR43 synthesized detectable levels of MBP
only if IPTG was added to the culture. The presence of
maltose or the absence of MalT protein had no effect on
MBP synthesis. The total amount of MBP synthesized in
response to IPTG was not significantly greater than the
amount observed in a haploid malE+ strain grown with
maltose. The results with class III plasmid pBAR5 were
somewhat different. Low but detectable levels ofMBP were
synthesized in the absence of either inducer. The addition of
either maltose or IPTG increased the amount of MBP
synthesized, the former having a slightly greater effect.
However, total MBP synthesis in the presence of maltose
was less than the synthesis by maltose-induced strains
harboring plasmid pCL. The combination of both maltose
and IPTG did not appear to increase the level of MBP
synthesis above the level observed with maltose alone.
Under the radiolabeling conditions used in these experi-
ments, some MBP was precipitated in its precursor form.
Also, it is important to note that plasmid-bearing strains
carried the internal, in-frame malEA312 deletion on the
chromosome. The ma1EA312 gene product was im-
munoprecipitated from antigen extracts by anti-MBP serum.
Synthesis of this truncated MBP species was maltose induc-
ible. However, when they were grown in the presence of
maltose, only strains carrying the class II and class III
plasmids synthesized high levels of this protein. Barely
detectable levels were synthesized in the strain carrying
plasmid pCL.
Genetic recombination of the malE18-1 mutation onto plas-
mid pBAR43 and suppression by prl4402. The malE18-1
signal sequence mutation was genetically recombined into
class II plasmid pBAR43 as described in Materials and
Methods, generating plasmid pBAR43-11. Strain BAR1091
harboring this plasmid remained phenotypically Mal- in the
presence of IPTG. The malE18-1 mutation introduces a
charged residue into the hydrophobic core of the MBP signal
peptide (6) (Fig. 2). Less than 2% of the malE18-1 product
synthesized is secreted to the periplasm and processed; the
remainder accumulates as unprocessed pMBP in the cyto-
plasm (4, 13). Workers have described mutations at several
genetic loci that restore export of MBP having a defective
signal peptide (1, 13). One such suppressor mutation, desig-
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FIG. 3. In vivo synthesis of MBP in the presence or absence of
maltose and IPTG. Cells were grown in glycerol minimal medium
and either were not induced (A) or were induced with IPTG (B and
E), maltose (C), or maltose and IPTG (D). The radiolabeled MBP
was immunoprecipitated and analyzed by SDS-PAGE and autora-
diography, as described in Materials and Methods. Lane 1, Precip-
itate obtained from strain ECB526; lanes 2 through 5, precipitates
obtained from strain BAR1091 carrying the plasmids pCL (lan,e 2),
pBAR43 (lane 3), pBAR1 (lane 4), and pBAR5 (lane 5). (E) MBP
species synthesized when the host strains harbored a malT deletion.
The positions of pMBP, mMBP, and the malEA312 gene product are
indicated. The gels shown in panels A, B, C, and D were 12.5%
acrylamide gels; the gel shown in panel E was a 10%o acrylamide gel.
Only the relevant portion of each autoradiograph is shown.
nated prlA402, recently was reported to be extremely effi-
cient at restoring export of the malE18-1 product (1). When
a prlA402 derivative of strain BAR1091 was transformed
with plasmid pBAR43-11, it was found to be phenotypically
Mal' when it was induced with IPTG.
MBP was precipitated from strain BAR1091 harboring
plasmid pBAR43-11 and from a prlA402 derivative of strain
BAR1091 harboring various plasmids. In this experiment,
MBP was precipitated from induced cells that had been
radiolabeled with [35S]methionine for 1 min and either not
chased (Fig. 4A) or chased in the presence of unlabeled
methionine for 10 min (Fig. 4B), as described in Materials
and Methods. For each of the strains synthesizing wild-type
MBP, under either malEp or lacUV5 regulation, no pMBP
was detected after the 10-min chase. This was observed with
strains harboring either a prlA+ allele (data not shown) or a
prIA402 allele. For a prlA+ strain synthesizing export-
defective MBP encoded by plasmid pBAR43-11, no mMBP
was detected after the 1-min pulse-label, and only barely
detectable levels of mature MBP were detected after the
10-min chase period. Large amounts of pMBP were ob-
served at both time points. In contrast, the presence of the
prlA402 allele resulted in maturation of more than 60% of the
total MBP by the end of the 10-min chase. Only a very small
fraction was mature after the 1-min labeling period.
In vitro synthesis and processing of MBP. Various plasmids
were tested for the ability to program MBP synthesis in vitro
by using an S30 coupled transcription-translation system
(Fig. 5). Using either class II or class III plasmid DNA
resulted in the synthesis of large amounts of MBP. The great
majority of MBP synthesized was found in its precursor
form. However, a faint band that migrated identically to
bona fide mMBP also was observed. In contrast to these
results, only a very faint band of pMBP was detected among
the in vitro products of plasmid pCL, which were carrying
malE+ under malEp control. The addition of maltose to the
reaction mixture had no effect on MBP synthesis (data not
shown). When plasmid pBAR43-11 was used to program
protein synthesis, large amounts of pMBP were produced,
but in this case no mMBP was evident. This pMBP species
with an altered signal peptide migrated slightly slower on
SDS-PAGE gels than the wild-type pMBP did. This small
anomaly in the migration rate also was observed for pMBP
synthesized in vivo (Fig. 4). The proteins migrating in the
region of pMBP and mMBP were precipitable with anti-MBP
serum (data not shown), confirming their identity as MBP
species. Synthesis of P-lactamase, which was encoded by
the bla gene of plasmid pCL and the different pBAR plas-
mids, served as an internal control for the ability of the
plasmids to function in the in vitro reaction. Note that the
level of P-lactamase synthesis programmed by each plasmid
was relatively constant. Thus, the differences in the level of
synthesis of MBP presumably reflected the efficiency of
transcription of the malE gene initiated from different pro-
moters.
We thought that the small amount of processing of wild-
type pMBP observed in the in vitro reactions was most likely
due to the presence of membrane vesicles in the S30 mix-
ture. Thus, in vitro synthesis of MBP was investigated by
using an S100 mixture and purified ribosomes (Fig. 6). In this
case, no mMBP band could be easily discerned when either
plasmid pBAR43 or pBAR43-11 was used. (The somewhat
indistinct bands migrating just below pMBP in this experi-
ment probably represented incomplete translation products.)
Finally, when membrane vesicles were included with the
S100 mixture and purified ribosomes, a substantial amount
of what appeared to be authentic mMBP, based upon its gel
mobility, was produced from pBAR43. The amount of
mMBP produced in this reaction was calculated by scanning
the autoradiogram shown in Fig. 6. Allowing for the fact that
the MBP signal peptide includes one-third of the total
methionine residues present in pMBP (12), approximately
30% of the pMBP synthesized was processed to the mature
form by the membrane vesicles. Once again, only pMBP was
produced from plasmid pBAR43-11. The reaction mixtures
VOL. 164, 1985
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FIG. 4. Synthesis and processing of plasmid-encoded MBP in prlA402 strains. Cells were grown and radiolabeled with [35S]methionine as
described in Materials and Methods. MBP species were immunoprecipitated and analyzed by SDS-PAGE, using a 10%o polyacrylamide gel,
and autoradiography. (A) Precipitates obtained after the 1-min pulse. (B) Precipitates obtained after the 10-min chase period. Lane 1,
Precipitate obtained from strain BAR1134 (strain ECB526 prIA402); lanes 2 through 5, precipitates obtained from strain BAR1092 (strain
ECB5Z6 maIEA312 prIA402) carrying plasmids pCL (lane 2), pBAR5 (lane 3), pBAR43 (lane 4), and pBAR43-11 (lane 5); lane 6, precipitate
obtained from strain BAR1091 (strain ECB526 malEA312 prIA+) carrying plasmid pBAR43-11. The positions of pMBP and mMBP are
indicated. Only the relevant portion of each autoradiograph is shown.
were centrifuged and separated into membrane (pellet) and
soluble fractions. The mMBP made from pBAR43 was found
to be entirely membrane associated, while the majority of
pMBP made from either pBAR43 or pBAR43-11 remained
soluble (data not shown).
DISCUSSION
We constructed a series of plasmids in which the malE
gene was placed under transcriptional control of the lacUVS
promoter-operator. These plasmids were grouped into three
classes based upon the phenotypes which they conferred
upon a malE deletion strain in the presence or absence of
IPTG. These groupings correlated well with the amount of
the malB regulatory interval separating the lacUVS promot-
er-operator and the malE ATG initiation codon. In the one
class I plasmid analyzed, the lacUVS sequence actually was
fused to a site just within the malE structural gene. This
plasmid did not complement a chromosomal malE deletion,
and we were unable to precipitate an IPTG-inducible MBP
species from a strain harboring this plasmid. For class II




FIG. 5. In vitro synthesis of MBP by using an S30 coupled transcription-translation system. An S30 mixture containing [35S]methionine
was programmed with various plasmids as described in Materials and Methods. Reaction mixtures were incubated for 30 min at 37°C. The
total array of radiolabeled protein products was analyzed by SDS-PAGE, using a 10% polyacrylamide gel and autoradiography. Samples were
preparfed for SDS-PAGE by mixing 5 ,ul of the reaction'mixture with 20 ,ul of 1.25 x sample buffer; 12.5 p.l was loaded per lane. Lane 1, Marker
pMBP and mMBP synthesized in vivo; lanes 2 through 12, radiolabeled protein products synthesized in vitro when the S30 mixture was
programmed with plasmids pBAR1 (lane 2), pBAR2 (lane 3), pBAR26 (lane 4), pBAR43 (lane 5), pBAR43-11 (lane 6), pBAR5 (lane 7), pBAR3
(lane 8), pCL (lane 9), pBR322 (lane 10), and ColEl (lane 11) and with no plasmid DNA (lane 12). The positions of pMBP, mMBP, and
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FIG. 6. In vitro synthesis of MBP in the presence or absence of membrane vesicles. MBP was synthesized in vitro by using coupled
transcription-translation systems programmed with either pla,smid pBAR43 (lanes B, D, and F) or plasmid pBAR43-11 (lanes C, E, and G).
The in vitro reactions were carried out by using an S30 mixture (lanes B and C), an S100 mixture with added ribosomes (lanes D and E), or
an S100 mixture with added ribosomeO and E. coli membrane vesicles (lanes F and G). The reaction mixtures were incubated for 60 min at
37°C, and reactions were stopped by adding 0.5 volume of 5 x sample buffer. The radiolabeled protein products were analyzed by SDS-PAGE,
using a 12% polyacrylamide gel, and autoradiography; 2.5 ,ul of sample was loaded into each lane. Lane A contained marker pMBP and mMBP
synthesized in vivo. Only the relevant portion of the autoradiograph is shown.
plasmids pBAR1, p13AR26, and pBAR43, expression of
malE was regulated solely by the lacUVS promoter-
operator. These three plasmids contained an intact malE
gene, but not the malEp -10 or -35 sequences that were
identified previously (7). Class II plasmid pBAR2 retained
108 bp upstream from the malE initiating ATG codon,
leaving intact the -10 and -35 sequences, as well as a site
thought to be a part of the malEp activation site for the MalT
protein (5, 7). The extent of malEp carried by plasmid
pBAR2 appears to be sufficient to permit weak MalT-
depeddent expression of malE in the absence of IPTG.
However, our lata indicate that maximal MalT-dependent
expression of the malEFG operon requires additional up-
stream sequences. Note that class III plasmids carry approx-
imately 200 bp upstream from the malE initiating ATG
codon, and strains harboring these plasmids are phenotypi-
cally Mal' in the absence of IPTG. Class III plasmid-
encoded MBP mRNA synthesis can be initiated from either
malEp or the lacUV5 promoter. However, even these class
III plasmids may be missing some information required for
MalT induction at 100% efficiency. Note that MalT-
dependent synthesis of MBP was somewhat reduced in a
strain harboring plasmid pBAR5 compared with a strain
harboring plasmid pCL (Fig. 3A and C).
It was interesting to find that strain BAR1091 harboring a
class III plasmid exhibited a stronger Mal' phenotype in the
absence of IPTG than the same strain harboring the parental
plasmid, pCL. This can be explained, by considering the
amounts of the maiB regulatory interval included on these
different plasmids. Plasmid pCL carries an intact malB
regulatory intet-val and, therefore, the MalT binding sites for
both the malEFG and maIK-lamB operons. The class III
plasmids lack at least one site thought to be required for the
interaction of the MalT protein with malKp (5, 7) (Fig. 2).
Synthesis of the MalT protein is not autoregulated. This
protein appears to be synthesized at relatively constant
levels under most growth conditions, although its synthesis
is subject to catabolite repression (10). For a strain harboring
multicopy plasmid pCL with its two MalT interaction sites,
it seems likely that almnost all of the MalT protein in the cell
binds to plasmid DNA. The result is much lower than normal
expression of the chromosomal malA and malB operons
required for growth on maltose as a carbon source. How-
ever, class III plasmids lack the malKp-MalT interaction site
and, therefore, do not have as severe a titration effect on
MalT protein as plasmid pCL does. Thus, in strains harbor-
ing class III plasmids, there is still sufficient MalT protein
available to efficiently induce chromosomal mal operons,
and such strains are fully Mal+. This is further supported by
our finding that strains harboring either a class II plasmid or
a class III plasmid synthesized high levels of the chromo-
somal malEA312 product when they were induced with
maltose. In contrast, strains harboring plasmid pCL synthe-
sized very low levels, indicating that insufficient MalT pro-
tein. was available to induce the chromosomal malEFG
operon.
In this study, we were somewhat surprised to find that the
presence in E. coli of the malE gene on a multicopy plasmid
under the regulatory control of malEp or the lacUV5 pro-
moter-operator or both did not result in a substantial over-
produdction of MBP under conditions that should have pro-
vidbd full induction. The malE gene dosage effect was easily
observed in a strain harboring plasmid pCL under noninduc-
ing conditions, when the basal level of MBP synthesis was
apprdximately 10-fold higher than the level seen in an
isogenic strain havidg a single chromosomal copy of the
rfalE gene. Whereas maltose induction of the latter strain
resulted in a 10-fold increase in MBP synthesis, which was
expected (17); induction of the plasmid-bearing strain re-
sulted in only a 2- to 3-fold increase in MBP synthesis.
Likewise, IPTG induction of strains harboring class II plas-
mids or maltose and IPTG induction of strains harboring
class III plasmids resulted in a rate of MBP synthesis that
was not significantly differetit than that seen ih the single-
copy strain. One possibility is that there is an upper limit on
the amount ofMBP that can be synthesized at any one time.
There is good evidence that synthesis and secretion of MBP
are obligately coupled events (15, 26). It could be that the
maximum amount of MBP that can be synthesized at any
one time is limited by the capacity of the secretory machin-
ery of a cell. This possibility is being investigated further.
We were able to genetically recombine the malE18-1
signal sequence mutation onto class II plasmid pBAR43 with
little difficulty, despite the fact that there was a relatively
small region of homologous DNA lying between this muta-
tion and the lacUV5-malE fusion joint. This indicates that
we should be able to conveniently place a variety of addi-
tional malE alleles encoding export-defective MBP (summa-
rized in reference 3) under lacUVS control by using an
identical approach. In response to IPTG, strain BAR1091
harboring plasmid pBAR43-11 synthesized large amounts of
pMBP, very little of which was processed to the mature
form. It was of interest to find that malE18-1, which is
exclusively under lacUV5 control, can be efficiently sup-
pressed by the prlA402 mutation. The mechanism by which
signal sequence mutations are suppressed by different prlA
alleles has not been determined yet. It is believed that
suppression most likely involves a direct interaction of the
prlA product with the signal peptide as it emerges from the
ribosome (13, 14). It has been suggested that this interaction
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might also be involved in the coupling of MBP synthesis and
secretion (3, 33). Our finding indicates that a specific mRNA
sequence upstream from the malE ATG initiation codon
most likely is not required for this interaction. We also found
that prlA402-mediated maturation of the plasmid-encoded
malE18-1 product occurs considerably slower than the mat-
uration observed in a malE+ strain. In a separate study, the
kinetics of MBP maturation in different priA strains was
studied in considerable detail (J. P. Ryan and P. J. Bassford,
Jr., J. Biol. Chem., in press).
A major goal of our research has been to develop a totally
in vitro system with which to study MBP synthesis, secre-
tion, and processing. Previous efforts to synthesize MBP in
a coupled in vitro E. coli transcription-translation system
have been unsuccessful, presumably due to an inability to
activate malEp. Using an S30 extract programmed with
plasmid pCL DNA, we found that the addition of maltose to
the in vitro reaction mixture did not induce MBP synthesis.
Such a result strongly suggests that the absence of functional
MalT protein is the underlying reason for inefficient malE+
expression in vitro. Unlike malEp, the lacUVS promoter is
very efficient in vitro and, when placed 5' to an intact malE
gene, directs high levels of MBP synthesis. In vitro MBP
synthesis was achieved by using each of the class II and
class III plasmids tested. The MBP synthesized was found
predomninantly as pMBP. A very small amount of what we
believe to be authentically processed mMBP was detected
among the in vitro protein products. Such processing may
have resulted from the presence of small metnbrane vesicles
present in the S30 mixture. No processing was observed
when we used purified ribosomes and an S100 mixture from
which all membranes should have been removed. Only
pMBP was observed in the protein products when plasmid
pBAR43-11 encoding export-defective MBP was used to
program in vitro protein synthesis in either system.
Muller and Blobel (25) have recently described experimen-
tal conditions under which three different E. coli exported
proteips synthesized in vitro were imported into inverted
mhembrane vesicles with up to 25% efficiency and processed
to their mature forms. Segregation into membrane vesicles
was demonstrated by the resistance of the processed forms
to externally added proteinase K. We prepared membrane
vesicles in the same manner and added these to our S100-
ribosome mixture synthesizing either wild-type or export-
defective MBP. We found that approximately 30% of the
wild-type MBP synthesized was processed to a form that
migrates on SDS-PAGE gels identically to bona fide mMBP.
Since mMBP is highly protease resistant (27), we were
unable to confirm import of the processed MBP into mem-
brane vesicles by simply scoring resistance to externally
added proteolytic enzymes. However, all of the processed
MBP pelleted with the membrane vesicles, strongly suggest-
ing that import had occurred. In contrast to these results, no
processing of export-defective MBP was observed in this
system. If import into membrane vesicles was not required
for processing, then presumably the malE18-1 product also
would have been processed in vitro, since this protein
matures in vivo when the block in export is suppressed by
altering the protein export machinery (1, 13).
In summary, we believe that we have developed a system
in which the synthesis, secretion, and processing of MBP
can be analyzed in vitro. We are presently attempting to
maximize the efficiency of in vitro MBP secretion and to
develop more direct methods of demonstrating MBP import
into inverted membrane vesicles. Since so much is known
concerning the synthesis and secretion of MBP, such a
system will hopefully permit us to dissect the E. coli protein
export pathway and further clarify the mode of action of the
products of various genes which have been implicated as
having important roles in this process.
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